McKesson price target raised to $571 from $537 at Barclays

Barclays raised the firm’s price target on McKesson to $571 from $537 and keeps an Overweight rating on the shares. The company’s fiscal Q3 featured puts and takes, with the headline beat and 1.5 point operational raise offset by a high bar and reiterated U.S. pharma profit growth, the analyst tells investors in a research note. The firm would opportunistic on any share weakness.